ArticleNature biotechnology2019
In vivo CRISPR screening in CD8 T cells with AAV-Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma.
Lupeng Ye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
124 papers cite itlatest 60 shown
this papercites it